BRAND NAME-WISEFEO-250 INJECTION
COMPOSITION: HYDROXYPROGESTRONE CAPROATE 250 MG INJECTION
PACKING: SINGLE INJECTION (COMBIPACK)
Wisefeo-250 injection (Hydroxyprogesterone Caproate Injection USP) is a sterile, long-acting preparation of the caproate ester of the aturallyoccurring progestational hormone, hydroxyprogesterone, in an oil solution for intramuscular use.
Hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into
secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of onadotropic hormone; it also shows slight estrogenic, androgenic, or corticoid effects as well, but should not be relied upon for these effects.
- -Administer wisefeo-250 injection intramuscularly at a dose of 250 mg (1 mL) once weekly.
- – Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation.
- – Continue administration of wisefeo-250 injection once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.
INDICATIONS OF WISEFEO-250 INJECTION
2.Prevention of preterm labour.
3.Dysfunctional uterine bleeding.
4.Advanced uterine cancer.